ResearcherUniversity of MichiganNo recent work listed
Meredith A. Collins
Matched on OpenAlex author ID A5020954608; NIH RePORTER profile ID 10598772. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 25
2012: 2 papers · 2013: 2 papers · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: 1 grant
Papers 7
- Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization. Co-author DOI 10.1101/gad.263327.115↗
- Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism. Co-author DOI 10.1093/carcin/bgv058↗
- CD44 regulates pancreatic cancer invasion through MT1-MMP. Co-author DOI 10.1158/1541-7786.mcr-14-0076↗
- Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Co-author DOI 10.1158/0008-5472.can-13-1558-t↗
- Kras as a key oncogene and therapeutic target in pancreatic cancer. Co-author DOI 10.3389/fphys.2013.00407↗
- Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. Co-author DOI 10.1172/jci59227↗
- Metastatic pancreatic cancer is dependent on oncogenic Kras in mice. Co-author DOI 10.1371/journal.pone.0049707↗
Grants 1
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marina Pasca di Magliano · 6 shared papers, 2012–2015 · strength 0.27
- Paper Kras as a key oncogene and therapeutic target in pancreatic cancer. DOI 10.3389/fphys.2013.00407↗
- Paper CD44 regulates pancreatic cancer invasion through MT1-MMP. DOI 10.1158/1541-7786.mcr-14-0076↗
- Paper Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism. DOI 10.1093/carcin/bgv058↗
- Yaqing Zhang · 5 shared papers, 2012–2015 · strength 0.19
- Paper CD44 regulates pancreatic cancer invasion through MT1-MMP. DOI 10.1158/1541-7786.mcr-14-0076↗
- Paper Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism. DOI 10.1093/carcin/bgv058↗
- Paper Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress… DOI 10.1158/0008-5472.can-13-1558-t↗
- Filip Bednar · 4 shared papers, 2012–2015 · strength 0.14
- Paper Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism. DOI 10.1093/carcin/bgv058↗
- Paper Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress… DOI 10.1158/0008-5472.can-13-1558-t↗
- Paper Metastatic pancreatic cancer is dependent on oncogenic Kras in mice. DOI 10.1371/journal.pone.0049707↗
- Diane M. Simeone · 2 shared papers, 2015 · strength 0.10
- Wei Jiang · 1 shared paper, 2015 · strength 0.06
- Kevin T. Nguyen · 1 shared paper, 2015 · strength 0.06
- Benoît Marchand · 1 shared paper, 2016 · strength 0.05
- Masaru Miyazaki · 1 shared paper, 2016 · strength 0.05
- Shigetsugu Takano · 1 shared paper, 2016 · strength 0.05
- Maximilian Reichert · 1 shared paper, 2016 · strength 0.05
- Steffen Heeg · 1 shared paper, 2016 · strength 0.05
- Koushik K. Das · 1 shared paper, 2016 · strength 0.05
- Takahiro Nishida · 1 shared paper, 2016 · strength 0.05
- Anil K. Rustgi · 1 shared paper, 2016 · strength 0.05
- Anirban Maitra · 1 shared paper, 2016 · strength 0.05
- Basil S. Bakir · 1 shared paper, 2016 · strength 0.05
- Jaime A. Eberle-Singh · 1 shared paper, 2015 · strength 0.04
- Heather K. Schofield · 1 shared paper, 2015 · strength 0.04
- Nabeel M. Bardeesy · 1 shared paper, 2015 · strength 0.04
- Martín E. Fernández-Zapico · 1 shared paper, 2015 · strength 0.04
- Kenneth P. Olive · 1 shared paper, 2015 · strength 0.04
- Ivy Chung · 1 shared paper, 2013 · strength 0.03
- Ben Z. Stanger · 1 shared paper, 2013 · strength 0.03
- Andrew D. Rhim · 1 shared paper, 2013 · strength 0.03
- Volkan N. Adsay · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.